Clinical Trial

Observational Study on GEP-and Pulm-NET Treated at FPG

Study acronym: ETNA-FPG
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated May 7, 2024 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
Observational ambispective monocentric study on the clinical, laboratory, pathological and molecular characteristics of patients suffering from gastroenteropancreatic tract and pulmonary neuroendocrine tumors and their prognostic and predictive value.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT06402695
Lead Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions Neuroendocrine Tumors, Gep Net, Pulmonary Neuroendocrine Neoplasm
Enrollment 650 participants
Start Date 2023-09-15
Primary Completion 2025-12 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2024-05-07